6,6,9A-TRIFLUORO-11.BETA.,16.ALPHA.,17.ALPHA.,21-TETRAHYDROXY-1,4-PREGNADIEN-3,20-DIONE-21-ACETATE 16,17-ACETONIDE
UNII 3A8QY089XN
Substance Identification & Data
This profile provides standardized clinical and technical data for 6,6,9a-trifluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxy-1,4-pregnadien-3,20-dione-21-acetate 16,17-acetonide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3A8QY089XN.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 37502-10-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H31F3O7 DWKVEHKKYLCIDJ-SQNISSEFSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6,6,9a-trifluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxy-1,4-pregnadien-3,20-dione-21-acetate 16,17-acetonide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.